Stage IV Ovarian Cancer AJCC v6 and v7

specific

Stage IA includes: T1a, N0, M0. T1a: Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)

76

Centers

129

Active Trials

Cancer Funding

Top Centers for Stage IV Ovarian Cancer AJCC v6 and v7(76)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.3
2
NCI Comprehensive
High-Volume Research Center
72.3
3
NCI Comprehensive
High-Volume Research Center
72.3
4
NCI Comprehensive
Active Research Program
66.9
5
NCI Comprehensive
Active Research Program
66.9
6
NCI Comprehensive
Active Research Program
66.9
7
Active Research Program
66.9
8
NCI Clinical
Active Research Program
66.9
9
Active Research Program
66.9
10
NCI Comprehensive
Active Research Program
66.9
11
Active Research Program
66.9
1266.9
13
Active Research Program
66.9
14
Active Research Program
66.9
15
Active Research Program
66.9
16
Active Research Program
66.9
17
Active Research Program
66.9
18
Active Research Program
66.9
19
NCI Comprehensive
Active Research Program
56.3
20
NCI Comprehensive
Active Research Program
56.3
21
NCI Comprehensive
Active Research Program
56.3
22
NCI Comprehensive
Active Research Program
56.3
23
NCI Comprehensive
Active Research Program
56.3
24
NCI Comprehensive
Active Research Program
56.3
25
NCI Comprehensive
Active Research Program
56.3
26
NCI Comprehensive
Active Research Program
56.3
27
NCI Comprehensive
Active Research Program
56.3
28
NCI Clinical
Active Research Program
56.3
29
NCI Comprehensive
Active Research Program
56.3
30
NCI Clinical
Active Research Program
56.3
31
Active Research Program
56.3
32
NCI Comprehensive
Active Research Program
56.3
33
NCI Clinical
Active Research Program
56.3
34
Active Research Program
56.3
35
NCI Comprehensive
Active Research Program
56.3
36
Active Research Program
56.3
37
Active Research Program
56.3
38
Active Research Program
56.3
39
Active Research Program
56.3
40
NCI Comprehensive
Active Research Program
41.2
41
NCI Comprehensive
Active Research Program
41.2
42
NCI Comprehensive
Active Research Program
41.2
43
NCI Comprehensive
Active Research Program
41.2
44
NCI Comprehensive
Active Research Program
41.2
45
NCI Comprehensive
Active Research Program
41.2
46
NCI Comprehensive
Active Research Program
41.2
47
NCI Comprehensive
Active Research Program
41.2
48
NCI Comprehensive
Active Research Program
41.2
49
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
41.2
50
NCI Comprehensive
Active Research Program
41.2
51
NCI Comprehensive
Active Research Program
41.2
52
NCI Comprehensive
Active Research Program
41.2
53
NCI Comprehensive
Active Research Program
41.2
54
NCI Comprehensive
Active Research Program
41.2
55
NCI Comprehensive
Active Research Program
41.2
56
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
41.2
57
NCI Comprehensive
Active Research Program
41.2
58
Active Research Program
41.2
59
NCI Comprehensive
Active Research Program
41.2
60
NCI Comprehensive
Active Research Program
41.2
61
NCI Comprehensive
Active Research Program
41.2
62
NCI Comprehensive
Active Research Program
41.2
63
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
41.2
64
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
41.2
65
Active Research Program
41.2
66
Active Research Program
41.2
67
Active Research Program
41.2
68
Active Research Program
41.2
69
Active Research Program
41.2
70
NCI Comprehensive
30.2
71
NCI Comprehensive
30.2
72
NCI Comprehensive
30.2
73
NCI Comprehensive
30.2
74
NCI Comprehensive
30.2
75
NCI Basic_laboratory
30.2
7630.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →